http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104892514-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94b3f527e5ca64ce33294133aaae82d7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
filingDate 2015-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb921dac9447a4d4967c1c5fb7bec60d
publicationDate 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104892514-A
titleOfInvention Novel imidazole compound
abstract The invention relates to a novel imidazole compound (represented as the formula I) and salt thereof. It is proved by the experiment that the novel imidazole compound and the salt of the compound can inhibit growth of cancer cells and are used for preparation of antineoplastic drugs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016184122-A1
priorityDate 2015-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407126721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415764391
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538790
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8500
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4432

Total number of triples: 25.